Investor Stock List
Ranked #1,507 of 8,699 institutional investors

EcoR1 Capital, LLC

San Francisco, CA

$2.03B
US stock portfolio at live prices · today +$25.6M (+1.28%)
Market closed. Prices as of Nov 20, 8:11 AM ET
Value at quarter end (Q3 2026)
$2.03B
Change from Q2 2026
+$17.5M (+0.87%)
Positions
29 · 8 new, 5 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $218M of stock. $92.4M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
ZYME 30.4%ANAB 18.4%CGON 7.55%ETON 7.46%TRAX 6.95%
StockSharesValue, live% of portfoliovs Q2 2026
ZYME Zymeworks Inc.22,970,388$617M30.4%Unchanged
ANAB AnaptysBio, Inc.7,880,094$374M18.4%Unchanged
CGON CG Oncology, Inc.1,871,892$153M7.55%Added +25%
ETON Eton Pharmaceuticals, Inc.2,470,920$152M7.46%Added +14%
TRAX First Tracks Biotherapeutics, Inc.3,174,519$141M6.95%Unchanged
AKTS Aktis Oncology, Inc.4,824,469$79.1M3.90%Unchanged
ANRO Alto Neuroscience Inc2,232,000$59.2M2.91%New
LKFT Lakefront Biotherapeutics NV1,667,119$55.7M2.74%Unchanged
ERAS Erasca, Inc.2,950,000$41.9M2.07%Added +794%
ATTO Attovia Therapeutics, Inc.2,024,010$31.5M1.55%New
NGNE Neurogene Inc.1,271,342$29.2M1.44%Unchanged
FULC Fulcrum Therapeutics, Inc.6,803,785$25.2M1.24%Added +4%
ORIC ORIC Pharmaceuticals, Inc.3,028,116$23.3M1.15%Reduced −55%
STOK Stoke Therapeutics, Inc.835,000$22.5M1.11%Added +14%
ZBIO Zenas BioPharma, Inc.789,500$19.8M0.97%Unchanged
XNCR Xencor, Inc.500,000$17.0M0.84%New
ADRX ADARx Pharmaceuticals, Inc.1,150,000$16.3M0.80%New
ETRA Electra Therapeutics, Inc.1,700,000$15.2M0.75%New
AURA Aura Biosciences, Inc.1,666,667$11.6M0.57%Unchanged
CAPR Capricor Therapeutics, Inc.1,376,580$10.4M0.51%New
ODTX Odyssey Therapeutics, Inc.555,555$10.2M0.50%Unchanged
ATRA Atara Biotherapeutics, Inc.1,552,000$9.8M0.48%Unchanged
BRVE Braveheart Bio, Inc.416,700$8.0M0.40%New
NRIX Nurix Therapeutics, Inc.375,000$5.1M0.25%Added +39%
ELOX Eloxx Pharmaceuticals, Inc.400,000$4.3M0.21%Unchanged
EIKN Eikon Therapeutics, Inc.855,634$4.1M0.20%Added +17%
BBOT BridgeBio Oncology Therapeutics, Inc.889,607$1.7M<0.1%Reduced −68%
AARD Aardvark Therapeutics, Inc.720,028$720K<0.1%Added +82%
CTNM Contineum Therapeutics, Inc.64,303$581K<0.1%New

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
MBX MBX Biosciences, Inc.388,500$20.7M
LEGN Legend Biotech Corporation800,000$12.9M
RLAY Relay Therapeutics, Inc.697,948$11.1M
PHAT Phathom Pharmaceuticals, Inc.625,000$3.2M
MREO Mereo BioPharma Group plc1,000,000$275K